Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study on skin reconstitution with Elidel (pimecrolimus) 1% cream in adults with atopic eczema and corticosteroid-induced skin damage
2005-004259-37Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pimecrolimus in atopic dermatitis (AD), sponsored by Novartis. Primary endpoint: Change in Dermatophot score. Started Jun 2006; status: completed.
02
Drugs
pimecrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-004259-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004259-37.